SpeeDx and Roche partner to expand access to antibiotic resistance tests
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season
Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology
The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London
Increase the effectiveness of human vaccines against infectious diseases such as COVID-19
Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
Company exploring further additional global capacity to provide broad and equitable access
New kit is designed to enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy
Join us on Monday, June 22, to learn how Olink’s latest immunoassay technology is taking proteomics to a new level
Your guide to choosing and implementing the best automated solutions for the clinical laboratory
Diagnostics for glycemic monitoring and ketosis testing on show
Participation will help advance liquid biopsy adoption by collaborating among key industry stakeholders
llumina's COVIDSeq aims to generate information about the genomic sequence of the virus
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work
Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics